Načítá se...
Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
Congestive cardiac failure accounts for 36% of childhood deaths in hypertrophic cardiomyopathy, and in infants with heart failure symptoms before two years of age, the mortality is extremely high unless treatment with beta-receptor antagonists is instituted. The mechanism of heart failure is not sys...
Uloženo v:
| Vydáno v: | Rev Recent Clin Trials |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Science Publishers
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4443781/ https://ncbi.nlm.nih.gov/pubmed/25198737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1574887109666140908125158 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|